nodes	percent_of_prediction	percent_of_DWPC	metapath
Moclobemide—CYP2D6—Carteolol—glaucoma	0.0876	0.136	CbGbCtD
Moclobemide—CYP1A2—Betaxolol—glaucoma	0.0718	0.112	CbGbCtD
Moclobemide—CYP2D6—Betaxolol—glaucoma	0.0592	0.092	CbGbCtD
Moclobemide—CYP2C19—Methazolamide—glaucoma	0.059	0.0917	CbGbCtD
Moclobemide—CYP2C9—Diclofenamide—glaucoma	0.057	0.0885	CbGbCtD
Moclobemide—CYP2C9—Dorzolamide—glaucoma	0.055	0.0855	CbGbCtD
Moclobemide—CYP2C19—Timolol—glaucoma	0.0501	0.0779	CbGbCtD
Moclobemide—CYP2C9—Methazolamide—glaucoma	0.049	0.0762	CbGbCtD
Moclobemide—CYP2D6—Methazolamide—glaucoma	0.0448	0.0697	CbGbCtD
Moclobemide—CYP1A2—Clonidine—glaucoma	0.0393	0.0612	CbGbCtD
Moclobemide—CYP2D6—Timolol—glaucoma	0.0381	0.0593	CbGbCtD
Moclobemide—CYP2D6—Clonidine—glaucoma	0.0324	0.0504	CbGbCtD
Moclobemide—MAOB—Dopamine metabolism—SOD1—glaucoma	0.00125	0.0547	CbGpPWpGaD
Moclobemide—MAOA—Dopamine metabolism—SOD1—glaucoma	0.000783	0.0343	CbGpPWpGaD
Moclobemide—CYP1A2—Sulindac Metabolic Pathway—CYP1B1—glaucoma	0.000696	0.0305	CbGpPWpGaD
Moclobemide—MAOA—Neurotransmitter Release Cycle—SLC6A13—glaucoma	0.000678	0.0297	CbGpPWpGaD
Moclobemide—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—glaucoma	0.000613	0.0269	CbGpPWpGaD
Moclobemide—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—glaucoma	0.000559	0.0245	CbGpPWpGaD
Moclobemide—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—glaucoma	0.000558	0.0245	CbGpPWpGaD
Moclobemide—MAOA—SIDS Susceptibility Pathways—LMX1B—glaucoma	0.000526	0.0231	CbGpPWpGaD
Moclobemide—MAOB—Tryptophan metabolism—CYP1B1—glaucoma	0.000509	0.0223	CbGpPWpGaD
Moclobemide—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—glaucoma	0.000509	0.0223	CbGpPWpGaD
Moclobemide—MAOA—Neurotransmitter Release Cycle—SLC6A1—glaucoma	0.000496	0.0217	CbGpPWpGaD
Moclobemide—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—glaucoma	0.000478	0.0209	CbGpPWpGaD
Moclobemide—MAOA—Melatonin metabolism and effects—CYP1B1—glaucoma	0.000462	0.0203	CbGpPWpGaD
Moclobemide—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—glaucoma	0.000435	0.0191	CbGpPWpGaD
Moclobemide—MAOB—Alpha-synuclein signaling—BAD—glaucoma	0.000428	0.0188	CbGpPWpGaD
Moclobemide—CYP1A2—Aflatoxin B1 metabolism—GSTM1—glaucoma	0.000425	0.0186	CbGpPWpGaD
Moclobemide—MAOA—Oxidative Stress—SOD1—glaucoma	0.000401	0.0176	CbGpPWpGaD
Moclobemide—Bradycardia—Betaxolol—glaucoma	0.000385	0.00115	CcSEcCtD
Moclobemide—Fatigue—Acetazolamide—glaucoma	0.000385	0.00115	CcSEcCtD
Moclobemide—Paraesthesia—Brimonidine—glaucoma	0.000385	0.00115	CcSEcCtD
Moclobemide—Nausea—Methazolamide—glaucoma	0.000383	0.00115	CcSEcCtD
Moclobemide—Hypotension—Dorzolamide—glaucoma	0.000383	0.00115	CcSEcCtD
Moclobemide—Dyspnoea—Brimonidine—glaucoma	0.000382	0.00114	CcSEcCtD
Moclobemide—Somnolence—Brimonidine—glaucoma	0.000381	0.00114	CcSEcCtD
Moclobemide—Hypotension—Travoprost—glaucoma	0.000381	0.00114	CcSEcCtD
Moclobemide—Shock—Pilocarpine—glaucoma	0.000381	0.00114	CcSEcCtD
Moclobemide—Tachycardia—Pilocarpine—glaucoma	0.000378	0.00113	CcSEcCtD
Moclobemide—Dyspepsia—Brimonidine—glaucoma	0.000377	0.00113	CcSEcCtD
Moclobemide—Hallucination—Betaxolol—glaucoma	0.000377	0.00113	CcSEcCtD
Moclobemide—Angina pectoris—Timolol—glaucoma	0.000376	0.00113	CcSEcCtD
Moclobemide—Hypotension—Brinzolamide—glaucoma	0.000376	0.00113	CcSEcCtD
Moclobemide—Hyperhidrosis—Pilocarpine—glaucoma	0.000374	0.00112	CcSEcCtD
Moclobemide—MAOA—Melatonin metabolism and effects—EDN1—glaucoma	0.000374	0.0164	CbGpPWpGaD
Moclobemide—Musculoskeletal discomfort—Dorzolamide—glaucoma	0.000373	0.00112	CcSEcCtD
Moclobemide—Tension—Clonidine—glaucoma	0.000372	0.00111	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Travoprost—glaucoma	0.000371	0.00111	CcSEcCtD
Moclobemide—Insomnia—Dorzolamide—glaucoma	0.00037	0.00111	CcSEcCtD
Moclobemide—Fatigue—Brimonidine—glaucoma	0.00037	0.00111	CcSEcCtD
Moclobemide—Feeling abnormal—Acetazolamide—glaucoma	0.000368	0.0011	CcSEcCtD
Moclobemide—Nervousness—Clonidine—glaucoma	0.000368	0.0011	CcSEcCtD
Moclobemide—Paraesthesia—Dorzolamide—glaucoma	0.000368	0.0011	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Brinzolamide—glaucoma	0.000367	0.0011	CcSEcCtD
Moclobemide—Dyspnoea—Dorzolamide—glaucoma	0.000365	0.00109	CcSEcCtD
Moclobemide—Visual impairment—Betaxolol—glaucoma	0.000365	0.00109	CcSEcCtD
Moclobemide—Insomnia—Brinzolamide—glaucoma	0.000364	0.00109	CcSEcCtD
Moclobemide—Somnolence—Dorzolamide—glaucoma	0.000364	0.00109	CcSEcCtD
Moclobemide—Dyspnoea—Travoprost—glaucoma	0.000363	0.00109	CcSEcCtD
Moclobemide—Hypotension—Pilocarpine—glaucoma	0.000362	0.00108	CcSEcCtD
Moclobemide—Paraesthesia—Brinzolamide—glaucoma	0.000361	0.00108	CcSEcCtD
Moclobemide—Dysuria—Timolol—glaucoma	0.000361	0.00108	CcSEcCtD
Moclobemide—Dyspepsia—Dorzolamide—glaucoma	0.00036	0.00108	CcSEcCtD
Moclobemide—Dyspnoea—Brinzolamide—glaucoma	0.000359	0.00108	CcSEcCtD
Moclobemide—Dyspepsia—Travoprost—glaucoma	0.000359	0.00107	CcSEcCtD
Moclobemide—Asthenia—Apraclonidine—glaucoma	0.000358	0.00107	CcSEcCtD
Moclobemide—Somnolence—Brinzolamide—glaucoma	0.000358	0.00107	CcSEcCtD
Moclobemide—Vision blurred—Clonidine—glaucoma	0.000357	0.00107	CcSEcCtD
Moclobemide—Decreased appetite—Dorzolamide—glaucoma	0.000356	0.00107	CcSEcCtD
Moclobemide—Urticaria—Acetazolamide—glaucoma	0.000355	0.00106	CcSEcCtD
Moclobemide—Tremor—Clonidine—glaucoma	0.000355	0.00106	CcSEcCtD
Moclobemide—Dyspepsia—Brinzolamide—glaucoma	0.000354	0.00106	CcSEcCtD
Moclobemide—Pruritus—Apraclonidine—glaucoma	0.000353	0.00106	CcSEcCtD
Moclobemide—Fatigue—Dorzolamide—glaucoma	0.000353	0.00106	CcSEcCtD
Moclobemide—Tinnitus—Betaxolol—glaucoma	0.000353	0.00106	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.000353	0.00106	CcSEcCtD
Moclobemide—Fatigue—Travoprost—glaucoma	0.000352	0.00105	CcSEcCtD
Moclobemide—Flushing—Betaxolol—glaucoma	0.000351	0.00105	CcSEcCtD
Moclobemide—Ill-defined disorder—Clonidine—glaucoma	0.000351	0.00105	CcSEcCtD
Moclobemide—Insomnia—Pilocarpine—glaucoma	0.00035	0.00105	CcSEcCtD
Moclobemide—Decreased appetite—Brinzolamide—glaucoma	0.00035	0.00105	CcSEcCtD
Moclobemide—Constipation—Travoprost—glaucoma	0.000349	0.00104	CcSEcCtD
Moclobemide—Agitation—Clonidine—glaucoma	0.000348	0.00104	CcSEcCtD
Moclobemide—Paraesthesia—Pilocarpine—glaucoma	0.000347	0.00104	CcSEcCtD
Moclobemide—Asthenia—Bimatoprost—glaucoma	0.000347	0.00104	CcSEcCtD
Moclobemide—Fatigue—Brinzolamide—glaucoma	0.000347	0.00104	CcSEcCtD
Moclobemide—Dyspnoea—Pilocarpine—glaucoma	0.000345	0.00103	CcSEcCtD
Moclobemide—Somnolence—Pilocarpine—glaucoma	0.000344	0.00103	CcSEcCtD
Moclobemide—Pruritus—Bimatoprost—glaucoma	0.000343	0.00103	CcSEcCtD
Moclobemide—Diarrhoea—Apraclonidine—glaucoma	0.000342	0.00102	CcSEcCtD
Moclobemide—Malaise—Clonidine—glaucoma	0.000341	0.00102	CcSEcCtD
Moclobemide—Dyspepsia—Pilocarpine—glaucoma	0.000341	0.00102	CcSEcCtD
Moclobemide—Syncope—Clonidine—glaucoma	0.00034	0.00102	CcSEcCtD
Moclobemide—Feeling abnormal—Dorzolamide—glaucoma	0.000337	0.00101	CcSEcCtD
Moclobemide—Decreased appetite—Pilocarpine—glaucoma	0.000336	0.00101	CcSEcCtD
Moclobemide—Feeling abnormal—Travoprost—glaucoma	0.000336	0.00101	CcSEcCtD
Moclobemide—Conjunctivitis—Timolol—glaucoma	0.000335	0.001	CcSEcCtD
Moclobemide—Gastrointestinal pain—Dorzolamide—glaucoma	0.000335	0.001	CcSEcCtD
Moclobemide—Palpitations—Clonidine—glaucoma	0.000335	0.001	CcSEcCtD
Moclobemide—MAOB—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000334	0.0146	CbGpPWpGaD
Moclobemide—Gastrointestinal pain—Travoprost—glaucoma	0.000333	0.000999	CcSEcCtD
Moclobemide—Loss of consciousness—Clonidine—glaucoma	0.000333	0.000997	CcSEcCtD
Moclobemide—Feeling abnormal—Brinzolamide—glaucoma	0.000332	0.000994	CcSEcCtD
Moclobemide—Constipation—Pilocarpine—glaucoma	0.000331	0.000991	CcSEcCtD
Moclobemide—Sweating—Timolol—glaucoma	0.00033	0.000989	CcSEcCtD
Moclobemide—Dizziness—Apraclonidine—glaucoma	0.00033	0.000989	CcSEcCtD
Moclobemide—Urticaria—Dorzolamide—glaucoma	0.000325	0.000974	CcSEcCtD
Moclobemide—CYP1A2—Estrogen Receptor Pathway—CYP1B1—glaucoma	0.000324	0.0142	CbGpPWpGaD
Moclobemide—Abdominal pain—Dorzolamide—glaucoma	0.000324	0.00097	CcSEcCtD
Moclobemide—Tension—Betaxolol—glaucoma	0.000323	0.000969	CcSEcCtD
Moclobemide—Dysgeusia—Betaxolol—glaucoma	0.000323	0.000967	CcSEcCtD
Moclobemide—Chest pain—Clonidine—glaucoma	0.000322	0.000965	CcSEcCtD
Moclobemide—Abdominal pain—Travoprost—glaucoma	0.000322	0.000965	CcSEcCtD
Moclobemide—Anxiety—Clonidine—glaucoma	0.000321	0.000962	CcSEcCtD
Moclobemide—Asthenia—Acetazolamide—glaucoma	0.000321	0.00096	CcSEcCtD
Moclobemide—Dizziness—Bimatoprost—glaucoma	0.00032	0.000959	CcSEcCtD
Moclobemide—Nervousness—Betaxolol—glaucoma	0.00032	0.000959	CcSEcCtD
Moclobemide—Urticaria—Brinzolamide—glaucoma	0.00032	0.000958	CcSEcCtD
Moclobemide—Feeling abnormal—Pilocarpine—glaucoma	0.000319	0.000955	CcSEcCtD
Moclobemide—Discomfort—Clonidine—glaucoma	0.000318	0.000954	CcSEcCtD
Moclobemide—Vomiting—Apraclonidine—glaucoma	0.000318	0.000951	CcSEcCtD
Moclobemide—Gastrointestinal pain—Pilocarpine—glaucoma	0.000316	0.000948	CcSEcCtD
Moclobemide—Dry mouth—Clonidine—glaucoma	0.000315	0.000944	CcSEcCtD
Moclobemide—Bradycardia—Timolol—glaucoma	0.000315	0.000943	CcSEcCtD
Moclobemide—Dermatitis—Apraclonidine—glaucoma	0.000315	0.000942	CcSEcCtD
Moclobemide—Headache—Apraclonidine—glaucoma	0.000313	0.000937	CcSEcCtD
Moclobemide—Confusional state—Clonidine—glaucoma	0.000312	0.000933	CcSEcCtD
Moclobemide—Vision blurred—Betaxolol—glaucoma	0.000311	0.00093	CcSEcCtD
Moclobemide—Tremor—Betaxolol—glaucoma	0.000309	0.000925	CcSEcCtD
Moclobemide—Hallucination—Timolol—glaucoma	0.000308	0.000922	CcSEcCtD
Moclobemide—Asthenia—Brimonidine—glaucoma	0.000308	0.000921	CcSEcCtD
Moclobemide—Abdominal pain—Pilocarpine—glaucoma	0.000306	0.000916	CcSEcCtD
Moclobemide—Ill-defined disorder—Betaxolol—glaucoma	0.000306	0.000916	CcSEcCtD
Moclobemide—Diarrhoea—Acetazolamide—glaucoma	0.000306	0.000916	CcSEcCtD
Moclobemide—Rash—Bimatoprost—glaucoma	0.000305	0.000914	CcSEcCtD
Moclobemide—Dermatitis—Bimatoprost—glaucoma	0.000305	0.000914	CcSEcCtD
Moclobemide—MAOA—Melatonin metabolism and effects—APOE—glaucoma	0.000304	0.0133	CbGpPWpGaD
Moclobemide—Shock—Clonidine—glaucoma	0.000304	0.000911	CcSEcCtD
Moclobemide—Pruritus—Brimonidine—glaucoma	0.000303	0.000909	CcSEcCtD
Moclobemide—Headache—Bimatoprost—glaucoma	0.000303	0.000909	CcSEcCtD
Moclobemide—Tachycardia—Clonidine—glaucoma	0.000302	0.000903	CcSEcCtD
Moclobemide—Hyperhidrosis—Clonidine—glaucoma	0.000299	0.000895	CcSEcCtD
Moclobemide—Visual impairment—Timolol—glaucoma	0.000298	0.000893	CcSEcCtD
Moclobemide—Malaise—Betaxolol—glaucoma	0.000297	0.00089	CcSEcCtD
Moclobemide—Nausea—Apraclonidine—glaucoma	0.000297	0.000889	CcSEcCtD
Moclobemide—Syncope—Betaxolol—glaucoma	0.000296	0.000885	CcSEcCtD
Moclobemide—Dizziness—Acetazolamide—glaucoma	0.000295	0.000885	CcSEcCtD
Moclobemide—Asthenia—Dorzolamide—glaucoma	0.000294	0.00088	CcSEcCtD
Moclobemide—Asthenia—Travoprost—glaucoma	0.000293	0.000876	CcSEcCtD
Moclobemide—Palpitations—Betaxolol—glaucoma	0.000291	0.000872	CcSEcCtD
Moclobemide—Pruritus—Dorzolamide—glaucoma	0.00029	0.000868	CcSEcCtD
Moclobemide—Loss of consciousness—Betaxolol—glaucoma	0.00029	0.000868	CcSEcCtD
Moclobemide—Asthenia—Brinzolamide—glaucoma	0.000289	0.000865	CcSEcCtD
Moclobemide—Hypotension—Clonidine—glaucoma	0.000289	0.000865	CcSEcCtD
Moclobemide—Pruritus—Travoprost—glaucoma	0.000288	0.000864	CcSEcCtD
Moclobemide—Tinnitus—Timolol—glaucoma	0.000288	0.000864	CcSEcCtD
Moclobemide—Nausea—Bimatoprost—glaucoma	0.000288	0.000862	CcSEcCtD
Moclobemide—Pruritus—Brinzolamide—glaucoma	0.000285	0.000853	CcSEcCtD
Moclobemide—Vomiting—Acetazolamide—glaucoma	0.000284	0.000851	CcSEcCtD
Moclobemide—Dizziness—Brimonidine—glaucoma	0.000284	0.000849	CcSEcCtD
Moclobemide—CYP2C19—Tamoxifen metabolism—CYP1B1—glaucoma	0.000283	0.0124	CbGpPWpGaD
Moclobemide—Musculoskeletal discomfort—Clonidine—glaucoma	0.000282	0.000843	CcSEcCtD
Moclobemide—Chest pain—Betaxolol—glaucoma	0.000281	0.000841	CcSEcCtD
Moclobemide—Myalgia—Betaxolol—glaucoma	0.000281	0.000841	CcSEcCtD
Moclobemide—Diarrhoea—Dorzolamide—glaucoma	0.00028	0.000839	CcSEcCtD
Moclobemide—Headache—Acetazolamide—glaucoma	0.00028	0.000838	CcSEcCtD
Moclobemide—Anxiety—Betaxolol—glaucoma	0.00028	0.000838	CcSEcCtD
Moclobemide—Insomnia—Clonidine—glaucoma	0.000279	0.000837	CcSEcCtD
Moclobemide—Diarrhoea—Travoprost—glaucoma	0.000279	0.000836	CcSEcCtD
Moclobemide—Asthenia—Pilocarpine—glaucoma	0.000278	0.000832	CcSEcCtD
Moclobemide—Paraesthesia—Clonidine—glaucoma	0.000277	0.000831	CcSEcCtD
Moclobemide—Discomfort—Betaxolol—glaucoma	0.000277	0.00083	CcSEcCtD
Moclobemide—Dyspnoea—Clonidine—glaucoma	0.000275	0.000825	CcSEcCtD
Moclobemide—Diarrhoea—Brinzolamide—glaucoma	0.000275	0.000825	CcSEcCtD
Moclobemide—Somnolence—Clonidine—glaucoma	0.000275	0.000823	CcSEcCtD
Moclobemide—Dry mouth—Betaxolol—glaucoma	0.000274	0.000822	CcSEcCtD
Moclobemide—Pruritus—Pilocarpine—glaucoma	0.000274	0.00082	CcSEcCtD
Moclobemide—Confusional state—Betaxolol—glaucoma	0.000271	0.000812	CcSEcCtD
Moclobemide—Dizziness—Dorzolamide—glaucoma	0.000271	0.000811	CcSEcCtD
Moclobemide—Rash—Brimonidine—glaucoma	0.00027	0.00081	CcSEcCtD
Moclobemide—Dermatitis—Brimonidine—glaucoma	0.00027	0.000809	CcSEcCtD
Moclobemide—Dizziness—Travoprost—glaucoma	0.00027	0.000808	CcSEcCtD
Moclobemide—Headache—Brimonidine—glaucoma	0.000269	0.000805	CcSEcCtD
Moclobemide—Decreased appetite—Clonidine—glaucoma	0.000269	0.000805	CcSEcCtD
Moclobemide—Fatigue—Clonidine—glaucoma	0.000266	0.000798	CcSEcCtD
Moclobemide—Dizziness—Brinzolamide—glaucoma	0.000266	0.000797	CcSEcCtD
Moclobemide—Nausea—Acetazolamide—glaucoma	0.000265	0.000795	CcSEcCtD
Moclobemide—Diarrhoea—Pilocarpine—glaucoma	0.000265	0.000793	CcSEcCtD
Moclobemide—Shock—Betaxolol—glaucoma	0.000265	0.000793	CcSEcCtD
Moclobemide—Tension—Timolol—glaucoma	0.000264	0.000791	CcSEcCtD
Moclobemide—Constipation—Clonidine—glaucoma	0.000264	0.000791	CcSEcCtD
Moclobemide—Dysgeusia—Timolol—glaucoma	0.000264	0.00079	CcSEcCtD
Moclobemide—Tachycardia—Betaxolol—glaucoma	0.000263	0.000786	CcSEcCtD
Moclobemide—Nervousness—Timolol—glaucoma	0.000262	0.000783	CcSEcCtD
Moclobemide—CYP2D6—Tamoxifen metabolism—CYP1B1—glaucoma	0.000261	0.0114	CbGpPWpGaD
Moclobemide—Vomiting—Dorzolamide—glaucoma	0.00026	0.00078	CcSEcCtD
Moclobemide—Hyperhidrosis—Betaxolol—glaucoma	0.00026	0.000779	CcSEcCtD
Moclobemide—CYP2C9—Tamoxifen metabolism—CYP1B1—glaucoma	0.000258	0.0113	CbGpPWpGaD
Moclobemide—Rash—Dorzolamide—glaucoma	0.000258	0.000773	CcSEcCtD
Moclobemide—Dermatitis—Dorzolamide—glaucoma	0.000258	0.000773	CcSEcCtD
Moclobemide—Rash—Travoprost—glaucoma	0.000257	0.00077	CcSEcCtD
Moclobemide—Dermatitis—Travoprost—glaucoma	0.000257	0.000769	CcSEcCtD
Moclobemide—Headache—Dorzolamide—glaucoma	0.000257	0.000768	CcSEcCtD
Moclobemide—Vomiting—Brinzolamide—glaucoma	0.000256	0.000767	CcSEcCtD
Moclobemide—Dizziness—Pilocarpine—glaucoma	0.000256	0.000766	CcSEcCtD
Moclobemide—Headache—Travoprost—glaucoma	0.000255	0.000765	CcSEcCtD
Moclobemide—Nausea—Brimonidine—glaucoma	0.000255	0.000763	CcSEcCtD
Moclobemide—Feeling abnormal—Clonidine—glaucoma	0.000255	0.000763	CcSEcCtD
Moclobemide—Rash—Brinzolamide—glaucoma	0.000254	0.00076	CcSEcCtD
Moclobemide—Vision blurred—Timolol—glaucoma	0.000254	0.00076	CcSEcCtD
Moclobemide—Dermatitis—Brinzolamide—glaucoma	0.000254	0.00076	CcSEcCtD
Moclobemide—Gastrointestinal pain—Clonidine—glaucoma	0.000253	0.000757	CcSEcCtD
Moclobemide—Headache—Brinzolamide—glaucoma	0.000252	0.000755	CcSEcCtD
Moclobemide—Hypotension—Betaxolol—glaucoma	0.000251	0.000753	CcSEcCtD
Moclobemide—CYP1A2—Estrogen metabolism—CYP1B1—glaucoma	0.00025	0.0109	CbGpPWpGaD
Moclobemide—Vomiting—Pilocarpine—glaucoma	0.000246	0.000737	CcSEcCtD
Moclobemide—Urticaria—Clonidine—glaucoma	0.000245	0.000735	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000245	0.000734	CcSEcCtD
Moclobemide—Abdominal pain—Clonidine—glaucoma	0.000244	0.000732	CcSEcCtD
Moclobemide—Rash—Pilocarpine—glaucoma	0.000244	0.000731	CcSEcCtD
Moclobemide—Dermatitis—Pilocarpine—glaucoma	0.000244	0.00073	CcSEcCtD
Moclobemide—Insomnia—Betaxolol—glaucoma	0.000243	0.000729	CcSEcCtD
Moclobemide—Nausea—Dorzolamide—glaucoma	0.000243	0.000729	CcSEcCtD
Moclobemide—Headache—Pilocarpine—glaucoma	0.000242	0.000726	CcSEcCtD
Moclobemide—Nausea—Travoprost—glaucoma	0.000242	0.000725	CcSEcCtD
Moclobemide—Paraesthesia—Betaxolol—glaucoma	0.000242	0.000724	CcSEcCtD
Moclobemide—Syncope—Timolol—glaucoma	0.000241	0.000723	CcSEcCtD
Moclobemide—Dyspnoea—Betaxolol—glaucoma	0.00024	0.000718	CcSEcCtD
Moclobemide—Nausea—Brinzolamide—glaucoma	0.000239	0.000716	CcSEcCtD
Moclobemide—Palpitations—Timolol—glaucoma	0.000238	0.000713	CcSEcCtD
Moclobemide—Dyspepsia—Betaxolol—glaucoma	0.000237	0.000709	CcSEcCtD
Moclobemide—Loss of consciousness—Timolol—glaucoma	0.000237	0.000709	CcSEcCtD
Moclobemide—Decreased appetite—Betaxolol—glaucoma	0.000234	0.0007	CcSEcCtD
Moclobemide—Hypertension—Timolol—glaucoma	0.000232	0.000696	CcSEcCtD
Moclobemide—Fatigue—Betaxolol—glaucoma	0.000232	0.000695	CcSEcCtD
Moclobemide—Constipation—Betaxolol—glaucoma	0.00023	0.000689	CcSEcCtD
Moclobemide—Nausea—Pilocarpine—glaucoma	0.00023	0.000688	CcSEcCtD
Moclobemide—Chest pain—Timolol—glaucoma	0.000229	0.000687	CcSEcCtD
Moclobemide—Myalgia—Timolol—glaucoma	0.000229	0.000687	CcSEcCtD
Moclobemide—Anxiety—Timolol—glaucoma	0.000228	0.000684	CcSEcCtD
Moclobemide—Discomfort—Timolol—glaucoma	0.000227	0.000678	CcSEcCtD
Moclobemide—Dry mouth—Timolol—glaucoma	0.000224	0.000672	CcSEcCtD
Moclobemide—MAOB—Biological oxidations—GSTT1—glaucoma	0.000223	0.00976	CbGpPWpGaD
Moclobemide—Asthenia—Clonidine—glaucoma	0.000222	0.000664	CcSEcCtD
Moclobemide—Feeling abnormal—Betaxolol—glaucoma	0.000222	0.000664	CcSEcCtD
Moclobemide—Confusional state—Timolol—glaucoma	0.000222	0.000664	CcSEcCtD
Moclobemide—CYP1A2—Tamoxifen metabolism—CYP1B1—glaucoma	0.000221	0.00968	CbGpPWpGaD
Moclobemide—CYP2C19—Melatonin metabolism and effects—CYP1B1—glaucoma	0.000219	0.00959	CbGpPWpGaD
Moclobemide—Pruritus—Clonidine—glaucoma	0.000219	0.000655	CcSEcCtD
Moclobemide—Shock—Timolol—glaucoma	0.000216	0.000648	CcSEcCtD
Moclobemide—Urticaria—Betaxolol—glaucoma	0.000214	0.00064	CcSEcCtD
Moclobemide—Hyperhidrosis—Timolol—glaucoma	0.000212	0.000636	CcSEcCtD
Moclobemide—Diarrhoea—Clonidine—glaucoma	0.000211	0.000633	CcSEcCtD
Moclobemide—MAOA—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.00021	0.00918	CbGpPWpGaD
Moclobemide—Hypotension—Timolol—glaucoma	0.000205	0.000615	CcSEcCtD
Moclobemide—Dizziness—Clonidine—glaucoma	0.000204	0.000612	CcSEcCtD
Moclobemide—CYP2D6—Melatonin metabolism and effects—CYP1B1—glaucoma	0.000201	0.00882	CbGpPWpGaD
Moclobemide—Musculoskeletal discomfort—Timolol—glaucoma	0.0002	0.0006	CcSEcCtD
Moclobemide—CYP1A2—Estrogen metabolism—GSTM1—glaucoma	0.0002	0.00875	CbGpPWpGaD
Moclobemide—Insomnia—Timolol—glaucoma	0.000199	0.000595	CcSEcCtD
Moclobemide—Paraesthesia—Timolol—glaucoma	0.000197	0.000591	CcSEcCtD
Moclobemide—Vomiting—Clonidine—glaucoma	0.000196	0.000588	CcSEcCtD
Moclobemide—Dyspnoea—Timolol—glaucoma	0.000196	0.000587	CcSEcCtD
Moclobemide—Somnolence—Timolol—glaucoma	0.000195	0.000585	CcSEcCtD
Moclobemide—Rash—Clonidine—glaucoma	0.000195	0.000584	CcSEcCtD
Moclobemide—Dermatitis—Clonidine—glaucoma	0.000195	0.000583	CcSEcCtD
Moclobemide—MAOA—Transmission across Chemical Synapses—SLC6A13—glaucoma	0.000194	0.00852	CbGpPWpGaD
Moclobemide—Headache—Clonidine—glaucoma	0.000194	0.00058	CcSEcCtD
Moclobemide—Dyspepsia—Timolol—glaucoma	0.000193	0.000579	CcSEcCtD
Moclobemide—Asthenia—Betaxolol—glaucoma	0.000193	0.000578	CcSEcCtD
Moclobemide—Decreased appetite—Timolol—glaucoma	0.000191	0.000572	CcSEcCtD
Moclobemide—Pruritus—Betaxolol—glaucoma	0.00019	0.00057	CcSEcCtD
Moclobemide—Fatigue—Timolol—glaucoma	0.000189	0.000568	CcSEcCtD
Moclobemide—MAOA—SIDS Susceptibility Pathways—HDAC9—glaucoma	0.000189	0.00827	CbGpPWpGaD
Moclobemide—Diarrhoea—Betaxolol—glaucoma	0.000184	0.000551	CcSEcCtD
Moclobemide—Nausea—Clonidine—glaucoma	0.000184	0.00055	CcSEcCtD
Moclobemide—Feeling abnormal—Timolol—glaucoma	0.000181	0.000542	CcSEcCtD
Moclobemide—Gastrointestinal pain—Timolol—glaucoma	0.00018	0.000538	CcSEcCtD
Moclobemide—Dizziness—Betaxolol—glaucoma	0.000178	0.000533	CcSEcCtD
Moclobemide—MAOB—Biological oxidations—CYP1B1—glaucoma	0.000177	0.00778	CbGpPWpGaD
Moclobemide—CYP2C19—Melatonin metabolism and effects—EDN1—glaucoma	0.000177	0.00776	CbGpPWpGaD
Moclobemide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000176	0.0077	CbGpPWpGaD
Moclobemide—Urticaria—Timolol—glaucoma	0.000175	0.000523	CcSEcCtD
Moclobemide—Abdominal pain—Timolol—glaucoma	0.000174	0.00052	CcSEcCtD
Moclobemide—Vomiting—Betaxolol—glaucoma	0.000171	0.000512	CcSEcCtD
Moclobemide—CYP1A2—Melatonin metabolism and effects—CYP1B1—glaucoma	0.000171	0.00748	CbGpPWpGaD
Moclobemide—Rash—Betaxolol—glaucoma	0.00017	0.000508	CcSEcCtD
Moclobemide—Dermatitis—Betaxolol—glaucoma	0.000169	0.000508	CcSEcCtD
Moclobemide—Headache—Betaxolol—glaucoma	0.000169	0.000505	CcSEcCtD
Moclobemide—CYP2D6—Melatonin metabolism and effects—EDN1—glaucoma	0.000163	0.00714	CbGpPWpGaD
Moclobemide—Nausea—Betaxolol—glaucoma	0.00016	0.000479	CcSEcCtD
Moclobemide—Asthenia—Timolol—glaucoma	0.000158	0.000472	CcSEcCtD
Moclobemide—MAOB—Metabolism—NARFL—glaucoma	0.000156	0.00684	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—CA5A—glaucoma	0.000156	0.00684	CbGpPWpGaD
Moclobemide—Pruritus—Timolol—glaucoma	0.000155	0.000466	CcSEcCtD
Moclobemide—Diarrhoea—Timolol—glaucoma	0.00015	0.00045	CcSEcCtD
Moclobemide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.00015	0.00658	CbGpPWpGaD
Moclobemide—MAOA—Neuronal System—SLC6A13—glaucoma	0.000149	0.00653	CbGpPWpGaD
Moclobemide—Dizziness—Timolol—glaucoma	0.000145	0.000435	CcSEcCtD
Moclobemide—CYP2C19—Melatonin metabolism and effects—APOE—glaucoma	0.000144	0.00631	CbGpPWpGaD
Moclobemide—MAOA—Transmission across Chemical Synapses—SLC6A1—glaucoma	0.000142	0.00624	CbGpPWpGaD
Moclobemide—MAOB—Biological oxidations—GSTM1—glaucoma	0.000142	0.00622	CbGpPWpGaD
Moclobemide—CYP2C19—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000142	0.00621	CbGpPWpGaD
Moclobemide—Vomiting—Timolol—glaucoma	0.00014	0.000419	CcSEcCtD
Moclobemide—MAOA—Biological oxidations—GSTT1—glaucoma	0.00014	0.00612	CbGpPWpGaD
Moclobemide—Rash—Timolol—glaucoma	0.000139	0.000415	CcSEcCtD
Moclobemide—Dermatitis—Timolol—glaucoma	0.000138	0.000415	CcSEcCtD
Moclobemide—CYP1A2—Melatonin metabolism and effects—EDN1—glaucoma	0.000138	0.00605	CbGpPWpGaD
Moclobemide—Headache—Timolol—glaucoma	0.000138	0.000412	CcSEcCtD
Moclobemide—MAOA—SIDS Susceptibility Pathways—NTRK2—glaucoma	0.000135	0.00592	CbGpPWpGaD
Moclobemide—CYP2D6—Melatonin metabolism and effects—APOE—glaucoma	0.000132	0.0058	CbGpPWpGaD
Moclobemide—Nausea—Timolol—glaucoma	0.000131	0.000391	CcSEcCtD
Moclobemide—CYP2C9—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000129	0.00566	CbGpPWpGaD
Moclobemide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000122	0.00536	CbGpPWpGaD
Moclobemide—CYP2C19—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000121	0.00529	CbGpPWpGaD
Moclobemide—CYP1A2—Tryptophan metabolism—CYP1B1—glaucoma	0.000118	0.00517	CbGpPWpGaD
Moclobemide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1B1—glaucoma	0.000118	0.00517	CbGpPWpGaD
Moclobemide—CYP1A2—Aryl Hydrocarbon Receptor—CYP1B1—glaucoma	0.000118	0.00517	CbGpPWpGaD
Moclobemide—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000113	0.00493	CbGpPWpGaD
Moclobemide—CYP1A2—Melatonin metabolism and effects—APOE—glaucoma	0.000112	0.00492	CbGpPWpGaD
Moclobemide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000112	0.00489	CbGpPWpGaD
Moclobemide—MAOA—Biological oxidations—CYP1B1—glaucoma	0.000111	0.00488	CbGpPWpGaD
Moclobemide—CYP2D6—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000111	0.00487	CbGpPWpGaD
Moclobemide—CYP1A2—Arachidonic acid metabolism—CYP1B1—glaucoma	0.00011	0.00483	CbGpPWpGaD
Moclobemide—CYP2C9—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.00011	0.00483	CbGpPWpGaD
Moclobemide—MAOA—Neuronal System—SLC6A1—glaucoma	0.000109	0.00478	CbGpPWpGaD
Moclobemide—MAOA—SIDS Susceptibility Pathways—BDNF—glaucoma	0.000101	0.00442	CbGpPWpGaD
Moclobemide—CYP2C19—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	9.92e-05	0.00435	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—CA5A—glaucoma	9.79e-05	0.00429	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—NARFL—glaucoma	9.79e-05	0.00429	CbGpPWpGaD
Moclobemide—MAOA—SIDS Susceptibility Pathways—IL1A—glaucoma	9.68e-05	0.00424	CbGpPWpGaD
Moclobemide—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	9.53e-05	0.00418	CbGpPWpGaD
Moclobemide—CYP1A2—Oxidation by Cytochrome P450—CYP1B1—glaucoma	9.41e-05	0.00412	CbGpPWpGaD
Moclobemide—CYP2D6—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	9.12e-05	0.004	CbGpPWpGaD
Moclobemide—CYP2C9—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	9.04e-05	0.00396	CbGpPWpGaD
Moclobemide—MAOA—SIDS Susceptibility Pathways—NGF—glaucoma	8.94e-05	0.00392	CbGpPWpGaD
Moclobemide—MAOA—SIDS Susceptibility Pathways—NR3C1—glaucoma	8.9e-05	0.0039	CbGpPWpGaD
Moclobemide—MAOA—Biological oxidations—GSTM1—glaucoma	8.9e-05	0.0039	CbGpPWpGaD
Moclobemide—CYP1A2—Phase II conjugation—GSTT1—glaucoma	8.81e-05	0.00386	CbGpPWpGaD
Moclobemide—CYP1A2—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	7.73e-05	0.00339	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—CA1—glaucoma	7.62e-05	0.00334	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—CTSA—glaucoma	7.38e-05	0.00323	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—CA2—glaucoma	6.97e-05	0.00305	CbGpPWpGaD
Moclobemide—CYP2C19—Biological oxidations—GSTT1—glaucoma	6.61e-05	0.0029	CbGpPWpGaD
Moclobemide—CYP2C19—Arachidonic acid metabolism—PTGS2—glaucoma	6.38e-05	0.0028	CbGpPWpGaD
Moclobemide—CYP2D6—Biological oxidations—GSTT1—glaucoma	6.08e-05	0.00267	CbGpPWpGaD
Moclobemide—CYP2C9—Biological oxidations—GSTT1—glaucoma	6.03e-05	0.00264	CbGpPWpGaD
Moclobemide—CYP2C9—Arachidonic acid metabolism—PTGS2—glaucoma	5.82e-05	0.00255	CbGpPWpGaD
Moclobemide—CYP1A2—Phase II conjugation—GSTM1—glaucoma	5.61e-05	0.00246	CbGpPWpGaD
Moclobemide—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—glaucoma	5.31e-05	0.00233	CbGpPWpGaD
Moclobemide—CYP2C19—Biological oxidations—CYP1B1—glaucoma	5.27e-05	0.00231	CbGpPWpGaD
Moclobemide—CYP2C19—Metapathway biotransformation—CYP1B1—glaucoma	5.2e-05	0.00228	CbGpPWpGaD
Moclobemide—CYP1A2—Biological oxidations—GSTT1—glaucoma	5.15e-05	0.00226	CbGpPWpGaD
Moclobemide—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	5.03e-05	0.00221	CbGpPWpGaD
Moclobemide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—glaucoma	5.03e-05	0.00221	CbGpPWpGaD
Moclobemide—CYP1A2—Arachidonic acid metabolism—PTGS2—glaucoma	4.97e-05	0.00218	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—CTSA—glaucoma	4.92e-05	0.00216	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—TXN—glaucoma	4.91e-05	0.00215	CbGpPWpGaD
Moclobemide—CYP2D6—Biological oxidations—CYP1B1—glaucoma	4.85e-05	0.00212	CbGpPWpGaD
Moclobemide—CYP2C9—Biological oxidations—CYP1B1—glaucoma	4.8e-05	0.00211	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—CA1—glaucoma	4.78e-05	0.0021	CbGpPWpGaD
Moclobemide—CYP2D6—Metapathway biotransformation—CYP1B1—glaucoma	4.78e-05	0.00209	CbGpPWpGaD
Moclobemide—CYP2C9—Metapathway biotransformation—CYP1B1—glaucoma	4.74e-05	0.00208	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—NARFL—glaucoma	4.63e-05	0.00203	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CA5A—glaucoma	4.63e-05	0.00203	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—CTSA—glaucoma	4.63e-05	0.00203	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—CTSA—glaucoma	4.49e-05	0.00197	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—CA2—glaucoma	4.37e-05	0.00192	CbGpPWpGaD
Moclobemide—MAOA—SIDS Susceptibility Pathways—VEGFA—glaucoma	4.27e-05	0.00187	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CA5A—glaucoma	4.26e-05	0.00187	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—NARFL—glaucoma	4.26e-05	0.00187	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—NARFL—glaucoma	4.23e-05	0.00185	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CA5A—glaucoma	4.23e-05	0.00185	CbGpPWpGaD
Moclobemide—CYP2C19—Biological oxidations—GSTM1—glaucoma	4.21e-05	0.00185	CbGpPWpGaD
Moclobemide—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	4.19e-05	0.00183	CbGpPWpGaD
Moclobemide—CYP2C19—Metapathway biotransformation—GSTM1—glaucoma	4.15e-05	0.00182	CbGpPWpGaD
Moclobemide—CYP1A2—Biological oxidations—CYP1B1—glaucoma	4.11e-05	0.0018	CbGpPWpGaD
Moclobemide—CYP1A2—Metapathway biotransformation—CYP1B1—glaucoma	4.05e-05	0.00177	CbGpPWpGaD
Moclobemide—CYP2D6—Biological oxidations—GSTM1—glaucoma	3.87e-05	0.0017	CbGpPWpGaD
Moclobemide—CYP2C9—Biological oxidations—GSTM1—glaucoma	3.84e-05	0.00168	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—CTSA—glaucoma	3.83e-05	0.00168	CbGpPWpGaD
Moclobemide—CYP2D6—Metapathway biotransformation—GSTM1—glaucoma	3.82e-05	0.00167	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—GSTT1—glaucoma	3.81e-05	0.00167	CbGpPWpGaD
Moclobemide—CYP2C9—Metapathway biotransformation—GSTM1—glaucoma	3.79e-05	0.00166	CbGpPWpGaD
Moclobemide—MAOA—SIDS Susceptibility Pathways—TNF—glaucoma	3.66e-05	0.00161	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—NARFL—glaucoma	3.61e-05	0.00158	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CA5A—glaucoma	3.61e-05	0.00158	CbGpPWpGaD
Moclobemide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	3.59e-05	0.00157	CbGpPWpGaD
Moclobemide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—glaucoma	3.59e-05	0.00157	CbGpPWpGaD
Moclobemide—CYP1A2—Biological oxidations—GSTM1—glaucoma	3.28e-05	0.00144	CbGpPWpGaD
Moclobemide—CYP1A2—Metapathway biotransformation—GSTM1—glaucoma	3.24e-05	0.00142	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—TXN—glaucoma	3.08e-05	0.00135	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—ABCA1—glaucoma	3.03e-05	0.00133	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—CYP1B1—glaucoma	3.03e-05	0.00133	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—GSTM1—glaucoma	2.43e-05	0.00106	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—GSTT1—glaucoma	2.39e-05	0.00105	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CA1—glaucoma	2.26e-05	0.000992	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CTSA—glaucoma	2.19e-05	0.000961	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—MTHFR—glaucoma	2.14e-05	0.000939	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CA1—glaucoma	2.08e-05	0.000912	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CA2—glaucoma	2.07e-05	0.000907	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CA1—glaucoma	2.06e-05	0.000905	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	2.02e-05	0.000887	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	2.02e-05	0.000887	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CTSA—glaucoma	2.02e-05	0.000884	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CTSA—glaucoma	2e-05	0.000876	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—APOE—glaucoma	2e-05	0.000875	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—CAV1—glaucoma	1.98e-05	0.000867	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CA2—glaucoma	1.9e-05	0.000835	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—ABCA1—glaucoma	1.9e-05	0.000834	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—CYP1B1—glaucoma	1.9e-05	0.000834	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CA2—glaucoma	1.89e-05	0.000827	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.84e-05	0.000809	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.84e-05	0.000809	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CA1—glaucoma	1.76e-05	0.000773	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CTSA—glaucoma	1.71e-05	0.000749	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CA2—glaucoma	1.61e-05	0.000707	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.58e-05	0.000691	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.58e-05	0.000691	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—GSTM1—glaucoma	1.52e-05	0.000667	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—NOS3—glaucoma	1.49e-05	0.000655	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—TXN—glaucoma	1.46e-05	0.000639	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—PTGS2—glaucoma	1.37e-05	0.000599	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—MTHFR—glaucoma	1.34e-05	0.00059	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—TXN—glaucoma	1.34e-05	0.000588	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.33e-05	0.000583	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—TXN—glaucoma	1.33e-05	0.000583	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.32e-05	0.000578	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—APOE—glaucoma	1.25e-05	0.000549	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—CAV1—glaucoma	1.24e-05	0.000544	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.21e-05	0.000532	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.2e-05	0.000527	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—TXN—glaucoma	1.14e-05	0.000498	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—GSTT1—glaucoma	1.13e-05	0.000496	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—GSTT1—glaucoma	1.04e-05	0.000456	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.04e-05	0.000454	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—GSTT1—glaucoma	1.03e-05	0.000452	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.03e-05	0.00045	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—NOS3—glaucoma	9.38e-06	0.000411	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	9.12e-06	0.0004	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—ABCA1—glaucoma	9.01e-06	0.000395	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CYP1B1—glaucoma	9.01e-06	0.000395	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GSTT1—glaucoma	8.81e-06	0.000386	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PTGS2—glaucoma	8.58e-06	0.000376	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	8.31e-06	0.000364	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CYP1B1—glaucoma	8.29e-06	0.000363	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—ABCA1—glaucoma	8.29e-06	0.000363	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—ABCA1—glaucoma	8.22e-06	0.00036	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CYP1B1—glaucoma	8.22e-06	0.00036	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—GSTM1—glaucoma	7.2e-06	0.000316	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	7.1e-06	0.000311	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CYP1B1—glaucoma	7.02e-06	0.000308	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ABCA1—glaucoma	7.02e-06	0.000308	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—GSTM1—glaucoma	6.62e-06	0.00029	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—GSTM1—glaucoma	6.57e-06	0.000288	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—MTHFR—glaucoma	6.37e-06	0.000279	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—APOE—glaucoma	5.93e-06	0.00026	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CAV1—glaucoma	5.87e-06	0.000257	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—MTHFR—glaucoma	5.85e-06	0.000257	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—MTHFR—glaucoma	5.8e-06	0.000254	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GSTM1—glaucoma	5.61e-06	0.000246	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—APOE—glaucoma	5.45e-06	0.000239	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—APOE—glaucoma	5.4e-06	0.000237	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CAV1—glaucoma	5.4e-06	0.000237	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CAV1—glaucoma	5.35e-06	0.000235	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—MTHFR—glaucoma	4.96e-06	0.000217	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—APOE—glaucoma	4.62e-06	0.000202	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CAV1—glaucoma	4.58e-06	0.000201	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—NOS3—glaucoma	4.44e-06	0.000195	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—NOS3—glaucoma	4.08e-06	0.000179	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PTGS2—glaucoma	4.06e-06	0.000178	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—NOS3—glaucoma	4.05e-06	0.000177	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PTGS2—glaucoma	3.73e-06	0.000164	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PTGS2—glaucoma	3.7e-06	0.000162	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—NOS3—glaucoma	3.46e-06	0.000152	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PTGS2—glaucoma	3.16e-06	0.000139	CbGpPWpGaD
